STAT3 and atherosclerosis: Inhibitors targeting ND and TAD can mediate the binding of STAT3 dimers and regulate DNA transcription, which may be useful for treating atherosclerosis by suppressing endothelial cell dysfunction, inflammation, and abnormal immune cell differentiation.